Performing Shares of the Day: United States Steel Corp. (NYSE:X), JPMorgan Chase & Co. (NYSE:JPM)

United States Steel Corp. (NYSE:X)

The shares of United States Steel Corp. (NYSE:X) started off the last trading session with the price of $38.2 while closing the day with the price of $34.5. The shares of United States Steel Corp. (NYSE:X) Fell -10.99% with the Loss of -3.7 points.

The shares of United States Steel Corp. (NYSE:X) traded with the day volume of 22.75 Million shares whereas its average trading volume is 13.43 Million.

While analyzing the past performance of the stock we can see that the shares of United States Steel Corp. (NYSE:X) Loss -10.23% in the last week while Falling -19.51% in the last month. Past quarter performance shows the green light with 1.95%. The semi-annual and annual performance shows 33.77% and -0.17% respectively.

Some critical values of the shares of United States Steel Corp. (NYSE:X) to be discussed here are: the beta which shows the value at 2.88 while Average True Range of United States Steel Corp. (NYSE:X) demonstrate the value at 2.36. The weekly and monthly volatility of the shares of United States Steel Corp. (NYSE:X) are indicated at 5.60% and 5.13%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 30.35.

While studying the financial position of the shares of United States Steel Corp. (NYSE:X), we can see that the Market capitalization of the company is at 6.04 Billion. The shares outstanding for the company is 175.12 Million and the shares float stands at 174.25 Million. The income of the company stand at 306 Million while the sales stand at 12.25 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.72, Price to Earnings or P/E is at 20.02, Price to Sales P/S show the value of 0.49, the Return on Asset ROA stood at 0.04 and the Return on Equity ROE depicted at 0.143 while Return on Investment ROI is at 0.093.


JPMorgan Chase & Co. (NYSE:JPM)

JPMorgan Chase & Co. (NYSE:JPM) started its previous trading session at $113.2 and closed at $109.95 showing a Fell of -4.17 Percent.

The Company traded with an average Volume of 15.21 Million whereas, its Day Volume stood at 21.86 Million.

Looking at the performance of the stock, JPMorgan Chase & Co. (NYSE:JPM) Loss -4.59% in the last week in its shares price and -4.55% in the last month. Quarterly performance shows a green of 3.23 Percent while Semi-Annual and Annual performances shows a 16.23 and 25.61 percent respectively.

Beta for JPMorgan Chase & Co. (NYSE:JPM) stands at 1.21 while the ATR (average true range) is at 2.34. The Stock’s Weekly and Monthly Volatility is 1.94% and 1.97% respectively showing a RSI value of 35.16.

While studying the financial position of the shares of JPMorgan Chase & Co. (NYSE:JPM), we can see that the Market capitalization of the company is at 380.83 Billion. The shares outstanding for the company is 3.46 Billion and the shares float stands at 3.44 Billion.

The Company generated an income of 24.47 Billion and the sales of 64.37 Billion in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $6.88 a share. P/E (price to earnings) and P/S (price to sales) values are 15.99 and 5.92 respectively.

The Return on Assets stands at 0.009, ROE shows a value of 0.098 and ROI for JPMorgan Chase & Co. (NYSE:JPM) is 0.069 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment